News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

3 Numbers That Make Gilead (GILD) Look Cheaper Than It Really Is



3/17/2017 5:55:15 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Shares of Gilead Sciences (NASDAQ:GILD) are trading at levels last seen in the first half of 2014, when trailing-12-month revenue and earnings were substantially lower than they are today. Investors have punished the company for dropping sales as its hepatitis C franchise faces pricing pressure and fewer patients starting therapy after the initial group of patients waiting for its treatments were treated and cured.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES